去整合素-金属蛋白酶17与大肠肿瘤发生发展的研究进展
Research Progress of Disintegrin-Metalloproteinase 17 and Tumor Occurrence and Development of Colon
摘要
目前认为肿瘤发生发展与抑癌基因失活或原癌基因激活有关。另外,缺陷DNA错配修复系统和体细胞突变的迅速积累,导致上皮组织稳态受到凋亡和有丝分裂过程失衡的干扰,凋亡抑制导致增殖增加和基因损害细胞清除减少[1]。众多研究表明多种基因表达产物如转化生长因子-β(transforminggrowthfactor-β,TGF-β)、
出处
《药品评价》
CAS
2012年第27期13-17,共5页
Drug Evaluation
参考文献35
-
1Williams GT, Smith CA. Mollecular regulation of apotosis: genetic control on cell death [J]. Cell, 1993; 74: 777-779.
-
2Kopp R, Rothbauer E, Ruge M, et al. Clinical implications of the EGF receptor/ligand system for minor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options [J]. Recent Results Cancer Res, 2003; 162:115-132.
-
3Damstrup L, Kuwada SK, Dempsey P J, et al. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis [J]. Br J Cancer, 1999, 80(7): 1012-1019.
-
4Blobel CE ADAMs: key components in EGFR signalling and development [J]. Nat Rev Mol Cell Biol, 2005, 6(1): 32-43.
-
5Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases turnout-necrosis factor-alpha from cells. Nature, 1997, 385(6618): 729-733.
-
6Tsakadze NL,Sithu SD,Sen U, et al. Tumor necrosis factor-alpha- converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (1CAM-l) [J]. J Biol Chem, 2006, 281 (6): 3157-3164.
-
7Garton KJ, Gough PJ, Blobel CP, et al. Tumor necrosis factor- alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) [J]. J Biol Chem, 2001, 276(41): 37993-38001.
-
8Nanba D, Mammoto A, Hashimoto K, et al. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export ofPLZF [J]. J Cell Biol, 2003, 163(3): 489-502.
-
9Higashiyama S, Nanba D. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk [J]. Bioehim Biophys Acta, 2005, 1751(1): 110-117.
-
10Merchant NB, Voskresensky I, Rogers CM, et al. TACE/ADAM- 17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer [J]. J Clin Cancer Res, 2008, 14(4): 1182-1191.
-
1王卿,闫凯.非小细胞肺癌组织中ADAM17的表达变化及意义[J].山东医药,2016,56(6):48-49. 被引量:3
-
2刘宏斌,朱燕,杨其昌,沈屹,张晓娟,陈浩.ADAM17蛋白在食管鳞癌组织中表达及其临床病理意义[J].江苏医药,2012,38(10):1180-1182. 被引量:4
-
3刘宏斌,杨其昌,沈屹,朱燕,张晓娟,陈浩.食管鳞状细胞癌组织中去整合素-金属蛋白酶17mRNA表达的临床病理意义[J].肿瘤研究与临床,2012,24(7):444-446. 被引量:3
-
4汪茜茜,钱章君,周炎.ADAM17在食管鳞状细胞癌组织及细胞中的表达变化及意义[J].山东医药,2015,55(16):52-53. 被引量:3
-
5刘爽,马荣,贺云龙,刘禹池,孙丽美.宫颈鳞状细胞癌中ADAM17的表达及其临床意义[J].现代生物医学进展,2016,16(15):2868-2871. 被引量:5
-
6陈祥荣,王向宇.去整合素-金属蛋白酶17在胶质瘤侵袭转移中的作用机制[J].中华神经医学杂志,2013,12(9):960-962. 被引量:5
-
7王春梅,刘宏斌.ADAM17蛋白在食管鳞癌中的表达及意义[J].交通医学,2012,26(5):411-412. 被引量:1
-
8陈曦,李依敏,万福生.miRNA-206与肿瘤发生发展的研究进展[J].南昌大学学报(医学版),2017,57(1):97-101. 被引量:3
-
9舒婷,姚军.核磷酸酶基因与肿瘤发生和发展的研究[J].检验医学与临床,2013,10(10):1282-1284. 被引量:1
-
10郑家芬,谭超.miRNAs参与调控肺癌发生发展的研究进展[J].现代预防医学,2016,43(8):1527-1532. 被引量:1